Company intelligence / Profile preview
Goodain (Beijing) Pharmaceutical Technology Co., Ltd.
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
Overview
Goodain focuses on high-barrier drug delivery systems, specifically for inhalation and nasal routes. They have successfully developed generic and value-added versions of complex respiratory and ophthalmic drugs that have reached clinical and commercial stages in partnership with larger pharmaceutical entities.
- Therapeutic areas
- OphthalmologyImmunologyPulmonology
- Modalities
- Small moleculePeptides
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Goodain (Beijing) Pharmaceutical Technology Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Goodain (Beijing) Pharmaceutical Technology Co., Ltd..